21-U.S.C.-360N-1

§360N-1 – §360N-1. Priority Review For Qualified Infectious Disease Products

Pathway

Title 21 > Chapter 9 > Subchapter V > Part A > Section 360n-1

Details

• Reference: Section 360n-1
• Legend: §360N-1 – §360N-1. Priority Review For Qualified Infectious Disease Products
• USCode Year: 2013

Provision Content

If the Secretary designates a drug under section 355f(d) of this title as a qualified infectious disease product, then the Secretary shall give priority review to any application submitted for approval for such drug under section 355(b) of this title.

(June 25, 1938, ch. 675, §524A, as added Pub. L. 112–144, title VIII, §802(a), July 9, 2012, 126 Stat. 1079.)

Effective Date

Pub. L. 112–144, title VIII, §802(b), July 9, 2012, 126 Stat. 1079, provided that: Section 524A of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 360n–1], as added by subsection (a), applies only with respect to an application that is submitted under section 505(b) of such Act (21 U.S.C. 355(b)) on or after the date of the enactment of this Act [July 9, 2012].

U.S. Encyclopedia of Law Coverage

Topic Map

• Browse the Topic Map in relation with Title 21 (Food And Drugs) guided by subject interests.